Pulmonary Embolism Therapeutics Market to Grow by USD 14.02 Billion from 2024-2028, Driven by Rising Health Risks and AI Redefining the Market - Technavio

Source :: Plus Company Updates. November 8, 2024
Publication Year :: 2024
Abstract: NEW YORK: Technavio has issued the following news release: Report with market evolution powered by AI - The global pulmonary embolism therapeutics market size is estimated to grow by USD [...]

Subjects :: Astellas Pharma Inc. -- Forecasts and trends
Amgen Inc. -- Forecasts and trends
Bayer AG -- Forecasts and trends
AbbVie Inc. -- Forecasts and trends
Patient compliance -- Forecasts and trends -- Health aspects
Pulmonary embolism -- Forecasts and trends -- Health aspects
Biotechnology industry -- Forecasts and trends -- Market size
Pharmaceutical industry -- Forecasts and trends -- Market size
Market trend/market analysis
General interest
News, opinion and commentary

Tools